Mediterranean Diet and Bacterial Translocation and Immune-activation in Patients With HIV
NCT03846206 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102
Last updated 2019-08-21
Summary
Evaluate if a change to a Mediterranean diet supplemented with nuts and olive oil decreases bacterial translocation and immune activation by a change in the microbiome in successfully treated HIV-1 infected patients with CD4\> 500cells/ml.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
mediterranean diet
a Mediterranean diet supplemented with 50 g / day of olive oil and 15g / day of nuts for three months
Sponsors & Collaborators
-
Hospital Clinic of Barcelona
lead OTHER
Principal Investigators
-
Felipe García, MD, PhD · Institut d'Investigacions Biomèdiques August Pi i Sunyer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-01
- Primary Completion
- 2019-09-01
- Completion
- 2019-12-01
Countries
- Spain
Study Locations
More Related Trials
-
Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
NCT00078247 ·Status: COMPLETED ·Phase: PHASE3
-
Examining HIV Treatment Adherence During Early Disease
NCT02419066 ·Status: COMPLETED
-
Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa
NCT02028676 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment
NCT01417988 ·Status: TERMINATED ·Phase: PHASE4
-
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
NCT00663234 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Trial of Vitamin D in HIV Progression
NCT01798680 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya
NCT00838292 ·Status: COMPLETED ·Phase: NA
-
The Effects of Nutritional Supplementation and Drug Abuse on HIV
NCT00149656 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication
NCT03794648 ·Status: COMPLETED ·Phase: NA
-
An Adaptive Randomized Controlled Trial
NCT05633056 ·Status: RECRUITING ·Phase: NA
-
Early HIV Therapy in Patients With High CD4 Cell Counts
NCT01479634 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis
NCT00004736 ·Status: COMPLETED ·Phase: PHASE1
-
International HIV Antiretroviral Adherence, Resistance and Survival
NCT01596322 ·Status: COMPLETED
-
Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda
NCT00342160 ·Status: COMPLETED
-
Effectiveness of Intensive Adherence Counselling Among People Living With HIV/AIDS With Low-level Viraemia in Uganda.
NCT05514418 ·Status: UNKNOWN ·Phase: NA
-
Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.
NCT05372510 ·Status: UNKNOWN
-
A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients
NCT00398996 ·Status: COMPLETED ·Phase: PHASE3
-
Determining Bacterial Communities in the Lungs of HIV-infected Individuals With COPD in Uganda.
NCT04070248 ·Status: UNKNOWN
-
Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa
NCT03848728 ·Status: COMPLETED ·Phase: NA
-
Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
NCT02043067 ·Status: COMPLETED
-
Immune Reconstitution in HIV Disease (IREHIV)
NCT01702974 ·Status: COMPLETED ·Phase: PHASE2
-
The Mochudi Prevention Project ART Protocol
NCT01583439 ·Status: TERMINATED ·Phase: NA
-
Package of Care to Improve Retention in ART and Mortality Among Treatment Naive HIV Infected Individuals
NCT03723525 ·Status: COMPLETED ·Phase: PHASE4
-
HIV PrEP Priming of Immune Effectors
NCT02593409 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women
NCT03282799 ·Status: COMPLETED ·Phase: PHASE2